Jiangsu Simcere Pharmaceutical Co., Ltd.

This Phase 3 trial tested whether adding the experimental drug BD0801 to standard chemotherapy can help women with recurrent ovarian cancer that no longer responds to platinum-based treatments. The study enrolled 421 participants and compared the combination to chemotherapy alone…

This early-stage trial tested the safety and tolerability of a new drug called SIM0278 in 60 healthy Chinese adults. Participants received either a single or multiple doses of the drug or a placebo via injection. The main goal was to check for side effects and how the drug moves …